job

Post-doctoral position in the field of cell cycle regulation and genetic stability

Le laboratoire étudie les voies de signalisation qui contrôle l’entrée des cellules humaines en mitose ainsi que leurs dérégulations en conditions pathologiques et les conséquences potentielles sur la stabilité génétique. La réplication complète du génome et l’initiation de l’entrée des cellules en mitose doivent être coordonnés dans l’espace et dans le temps pour préserver l’intégrité …

event

From cells to tissues: quantitative approaches to life!

La conférence « Physique de la cellule au tissu, Celltiss Days 2019 » a pour objet l’étude quantitative des processus biologiques allant de l’échelle moléculaire à l’échelle cellulaire et tissulaire. Cette conférence se tiendra du 5 au 7 novembre 2019 au “Belambra Club Les Criques” situé près de la presqu’île de Giens. Cette conférence fait …

event

Multimodality Imaging in Life Science, Vienna, Austria, 21-22 of November

BioImagingAustria/CMI (https://www.bioimaging-austria.at/web/pages/comulis-cmi-conference-2019.php) & COMULIS (https://www.comulis.eu/) have joined forces to host this year’s Conference on Multimodality Imaging in Life Sciences in the Natural History Museum in Vienna on Nov 21st & 22nd – with a beautiful line-up of renowned speakers in the field of multimodality covering biological and preclinical imaging and correlation software. The preliminary agenda …

job

Open postdoctoral position in the Jaulin lab to study collective migration

The Gustave Roussy institute is located in the Paris area and the largest comprehensive cancer center in Europe and provides a vibrant clinical and scientific environment. Research at GR institute covers a wide range of subjects in the field of cancer biology, from fundamental mechanisms to clinical trials and favors interaction between scientists and medical …

job

Bourse postdoctorale en oncologie thoracique, résistances aux thérapies ciblées

Research Description Our team, located in the Cancer Research Center of Toulouse (CRCT), INSERM U1037 (https://www.crct-inserm.fr/en/), is interested in targeted therapies that are used as standard of care for lung cancer harboring oncogenic addictions such as EGFR mutations. Despite the improved clinical outcomes derived from the introduction of EGFR tyrosine kinase inhibitors (EGFR-TKI), the overall …